Continuity on the Management Board of Bertrandt AG Ehningen, March 24, 2023 – Continuity on the Management Board of Bertrandt AG. Michael Lücke (Member of the Management Board – Sales) and Markus Ruf (Member of the Management Board – Finance) have been confirmed in their positions and have been appointed for a further five years.… Read More: Bertrandt sets the course for the future on the Management… »
Aduhelm by Biogen Source: Biogen The FDA’s approval of Biogen‘s Alzheimer’s drug Aduhelm was a landmark moment in the life of Dr. Paul Aisen. The director of the Alzheimer’s Therapeutic Research Institute at USC has spent the past three decades focused on treating the neurodegenerative disease, and in recent years helped shepherd this particular drug… Read More: Biogen Alzheimer’s drug and the battle over dementia treatment of… »
This week, Raley’s, a grocery chain based in California, released its first-ever Raley’s 2020 Impact Report “Imagine a grocery store with a higher purpose,” the landing page for the company’s social impact resources calls us to do. In today’s post, I explore — or chew on, if you will — Raley’s Report through the lens… Read More: Chewing on Raley’s Social Impact Report: Re-Imagining the Future of… »
Receiving an initial antibiotic prescription for a viral acute respiratory infection — the type of infection that doesn’t respond to antibiotics — increases the likelihood that a patient or their spouse will seek care for future such infections and will receive subsequent antibiotic prescriptions, according to the findings of a study from Harvard Medical School… Read More: Clinicians who prescribe unnecessary antibiotics fuel future antibiotic use »